Zevra Therapeutics Inc. (NASDAQ: ZVRA)
$8.6200
+0.0300 ( +0.82% ) 114.0K
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Market Data
Open
$8.6200
Previous close
$8.5900
Volume
114.0K
Market cap
$457.97M
Day range
$8.5000 - $8.7540
52 week range
$4.2000 - $9.7600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Dec 06, 2024 |
8-k | 8K-related | 16 | Nov 22, 2024 |
10-q | Quarterly Reports | 78 | Nov 13, 2024 |
8-k | 8K-related | 16 | Nov 12, 2024 |
4 | Insider transactions | 1 | Oct 16, 2024 |
8-k | 8K-related | 16 | Sep 20, 2024 |
10-q | Quarterly Reports | 79 | Aug 14, 2024 |
8-k | 8K-related | 16 | Aug 13, 2024 |
8-k | 8K-related | 17 | Aug 09, 2024 |
8-k | 8K-related | 13 | Aug 08, 2024 |